More on AMRN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.88 |
|
|||
| Open | $4.93 | ||||
| 52 Wk High | $3.65 | ||||
| 52 Wk Low | $1.24 | ||||
| Day High | $4.97 | ||||
| Day Low | $4.85 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,854,035 | ||||
- Amarin Corporation (AMRN) Symphony Data Shows Vacepta in Uptrend - Cantor Fitzgerald
- Form 4 AMARIN CORP PLC\UK For: Jun 03 Filed by: STACK DAVID M
- Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021
- Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021
- Form 4 AMARIN CORP PLC\UK For: May 28 Filed by: Berg Aaron
- Form 4 AMARIN CORP PLC\UK For: May 28 Filed by: Kalb Michael Wayne
- Form 4 AMARIN CORP PLC\UK For: May 28 Filed by: Ketchum Steven B
- Form 4 AMARIN CORP PLC\UK For: May 28 Filed by: Kennedy Joseph T
- Form 4 AMARIN CORP PLC\UK For: May 28 Filed by: THERO JOHN F
- CinCor Pharma Announces Appointments of Three Experienced Independent Members to Its Board of Directors
Entities mentioned with AMRN
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- AdCom | View Related Stories »
- Options | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
